Request Clinical Starter Kits for Your Patients Today! Request Now

 Digestive Health STUDIES

Tocotrienols as adjunct therapy for chronic diseases, a comprehensive review

Highlights Includes over 3 decades of published research (preclinical & human studies) Research related to common diseases addressed Applications for cardiovascular, cerebrovascular, neurodegenerative diseases & more Summary This comprehensive review...
on February 25, 2020

Resveratrol improves disease activity and quality of life in people with ulcerative colitis, study shows

Highlights Randomized, double-blind, placebo-controlled trial with 56 adults with mild-to-moderate ulcerative colitis Supplementation consists of trans-resveratrol (500 mg/day) for 6 weeks Resveratrol significantly increases body’s antioxidant status, reduces disease activity and improves...
on February 25, 2020

PepZinGI® zinc-carnosine protects the small intestine from NSAID-induced injury, study shows.

Highlights PepZinGI® zinc-carnosine protects the small intestine from NSAID-induced injury in healthy adults. Effective dosage is 37.5 mg, twice daily Action mediated through stabilizing gut permeability Summary This double-blind, placebo-controlled,...
on February 25, 2020

PepZinGI® improves standard therapy to eradicate Helicobacter pylori, study shows

Highlights Multicenter, randomized, open-label, controlled study 303 patients with H. pylori-associated gastritis on standard drug therapy Addition of PepZinGI® significantly improves H. pylori eradication Effective dosage is as low as 75 mg, twice daily, for...
on February 25, 2020

Healthy and pre-diabetic adults achieve better gut microflora balance with PreticX™ xylooligosaccharides, study shows

Highlights Randomized, double-blind, placebo-controlled pilot study with healthy (n=16) and pre-diabetic (n=13) adults Supplementation consists of 2 g/day xylooligosaccharides (XOS) from PreticX™ for 8 weeks Compared to placebo, PreticX™ XOS has a...
on February 25, 2020
"